Comparison of effectiveness and safety of high-power vs. conventional-power radiofrequency ablation for treatment of atrial fibrillation
Copyright © 2022 Cui, Qu, Zhang, Wu, Zhang, Shi and Liu..
Aim: To compare high-power (HP) vs. conventional-power (CP) radiofrequency ablation for atrial fibrillation (AF).
Methods: We retrospectively enrolled AF patients undergoing CP (30-40 W, 43 patients) or HP (50 W, 49 patients) radiofrequency ablation. Immediate pulmonary vein (PV) single-circle isolation, PV-ablation time, AF recurrence, AF recurrence-free survival, and complications were analyzed.
Results: Diabetes was more common in the CP group than in the HP group (27.91% vs. 10.20%, P = 0.029). The left PV single-circle isolation rate (62.79% vs. 65.31%), right PV single-circle isolation rate (48.84% vs. 53.06%), and bilateral PV single-circle isolation rate (32.56% vs. 38.78%; all P > 0.05) did not differ between the groups. Single-circle ablation times for the left PVs (12.79 ± 3.39 vs. 22.94 ± 6.39 min), right PVs (12.18 ± 3.46 vs. 20.67 ± 5.44 min), and all PVs (25.85 ± 6.04 vs. 45.66 ± 11.11 min; all P < 0.001) were shorter in the HP group. Atrial fibrillation recurrence within 3 months (13.95% vs. 18.37%), at 3 months (11.63% vs. 8.16%), and at 6 months after ablation (18.60% vs. 12.24%; all P > 0.05) was similar in both groups. Atrial fibrillation recurrence-free survival did not differ between the groups (Kaplan-Meier analysis). Cardiac rupture and pericardial tamponade did not occur in any patient. Pops occurred in 2 and 0 patients in the HP and CP groups, respectively (4.08% vs. 0.00%, P = 0.533).
Conclusion: High-power ablation improved operation time and efficiency without increasing complications.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
---|---|
Enthalten in: |
Frontiers in cardiovascular medicine - 9(2022) vom: 28., Seite 988602 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Cui, Penghui [VerfasserIn] |
---|
Links: |
---|
Themen: |
Atrial fibrillation |
---|
Anmerkungen: |
Date Revised 24.12.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3389/fcvm.2022.988602 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM350732906 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM350732906 | ||
003 | DE-627 | ||
005 | 20231226045648.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3389/fcvm.2022.988602 |2 doi | |
028 | 5 | 2 | |a pubmed24n1169.xml |
035 | |a (DE-627)NLM350732906 | ||
035 | |a (NLM)36561771 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Cui, Penghui |e verfasserin |4 aut | |
245 | 1 | 0 | |a Comparison of effectiveness and safety of high-power vs. conventional-power radiofrequency ablation for treatment of atrial fibrillation |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 24.12.2022 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright © 2022 Cui, Qu, Zhang, Wu, Zhang, Shi and Liu. | ||
520 | |a Aim: To compare high-power (HP) vs. conventional-power (CP) radiofrequency ablation for atrial fibrillation (AF) | ||
520 | |a Methods: We retrospectively enrolled AF patients undergoing CP (30-40 W, 43 patients) or HP (50 W, 49 patients) radiofrequency ablation. Immediate pulmonary vein (PV) single-circle isolation, PV-ablation time, AF recurrence, AF recurrence-free survival, and complications were analyzed | ||
520 | |a Results: Diabetes was more common in the CP group than in the HP group (27.91% vs. 10.20%, P = 0.029). The left PV single-circle isolation rate (62.79% vs. 65.31%), right PV single-circle isolation rate (48.84% vs. 53.06%), and bilateral PV single-circle isolation rate (32.56% vs. 38.78%; all P > 0.05) did not differ between the groups. Single-circle ablation times for the left PVs (12.79 ± 3.39 vs. 22.94 ± 6.39 min), right PVs (12.18 ± 3.46 vs. 20.67 ± 5.44 min), and all PVs (25.85 ± 6.04 vs. 45.66 ± 11.11 min; all P < 0.001) were shorter in the HP group. Atrial fibrillation recurrence within 3 months (13.95% vs. 18.37%), at 3 months (11.63% vs. 8.16%), and at 6 months after ablation (18.60% vs. 12.24%; all P > 0.05) was similar in both groups. Atrial fibrillation recurrence-free survival did not differ between the groups (Kaplan-Meier analysis). Cardiac rupture and pericardial tamponade did not occur in any patient. Pops occurred in 2 and 0 patients in the HP and CP groups, respectively (4.08% vs. 0.00%, P = 0.533) | ||
520 | |a Conclusion: High-power ablation improved operation time and efficiency without increasing complications | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a atrial fibrillation | |
650 | 4 | |a catheter ablation | |
650 | 4 | |a conventional-power | |
650 | 4 | |a effectiveness and safety | |
650 | 4 | |a high-power | |
700 | 1 | |a Qu, Yunpeng |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Jichang |e verfasserin |4 aut | |
700 | 1 | |a Wu, Junduo |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Jing |e verfasserin |4 aut | |
700 | 1 | |a Shi, Yongfeng |e verfasserin |4 aut | |
700 | 1 | |a Liu, Bin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Frontiers in cardiovascular medicine |d 2014 |g 9(2022) vom: 28., Seite 988602 |w (DE-627)NLM255534736 |x 2297-055X |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2022 |g day:28 |g pages:988602 |
856 | 4 | 0 | |u http://dx.doi.org/10.3389/fcvm.2022.988602 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 9 |j 2022 |b 28 |h 988602 |